Wafra Inc’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-701,127
Closed -$20.6M 63
2021
Q1
$20.6M Sell
701,127
-757,756
-52% -$23.3M 0.86% 46
2020
Q4
$44.7M Buy
1,458,883
+311,572
+27% +$9.51M 2% 16
2020
Q3
$32M Buy
1,147,311
+229,393
+25% +$5.81M 1.81% 18
2020
Q2
$19.7M Sell
917,918
-803,192
-47% -$17.7M 1.25% 36
2020
Q1
$38.5M Buy
+1,721,110
New +$47.1M 2.95% 7

Other funds holding ELAN

Wafra Inc's ELAN Position: Q2 2021 in Review

Wafra Inc sold out of Elanco Animal Health (ELAN) in Q2 2021, closing a stake of 701,127 shares — an estimated $20.6M sold.

Wafra Inc first reported a position in ELAN in Q1 2020 and held it in 5 quarters. The position peaked at $44.7M in Q4 2020. 479 funds tracked by Wall St. Rank hold ELAN as of Q2 2021.

  • Wafra Inc reported no remaining Elanco Animal Health position as of Q2 2021 after selling out during the quarter.
  • Wafra Inc sold 701,127 Elanco Animal Health shares in Q2 2021, an estimated $20.6M.
  • Wafra Inc first reported a position in Elanco Animal Health in Q1 2020 and held it in 5 quarters.
  • Wafra Inc's Elanco Animal Health position peaked at $44.7M in Q4 2020.
  • 479 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2021.

Based on Wafra Inc's 13F filing for Q2 2021, filed 6 Aug 2021.